tbuckley/cabot-search huggingface dataset:
New Names
Journal: JAMA (1967)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Recent advances in freeze-preservation of red blood cells
Authors: C. R. Valeri
Journal: JAMA (1969)

The methods currently in clinical use for freezing human red blood cells (RBC) require the intracellular additive, glycerol, either in high concentration (approximately 45% W/V) with the slow freeze-thaw technique, or in low concentration (approximately 18% W/V) with the rapid freeze-thaw technique. The major technological problem in the current methods is the removal of the glycerol. Postthaw washing is presently accomplished by serial centrifugation ("batch washing"), continuous centrifugation, or a dilution procedure with recovery of RBC by agglomeration. Recent advances in the use of continuous centrifugation are extremely encouraging. However, for widespread clinical application of this approach disposable washing material Is urgently needed.
Erratum
Journal: BMJ (1927)

ARECURRENT EPISTAXIS.DR.W. NUNAW (police surgeon, Bombay), having noticed several inquiries abouit the treatmeut of recurrent epistaxis, writes to suggest resort to nmental suggestion."'Anyone," he says, "who has had opportunities of observing the results of suggestion in case3 of spasmodic dysmenorrhoea and menorrhagia, eiiuresis, and pylorospasm will have no difficulty in appreciating the value of suggestion-therapy in tlhe control of contractions of unstriped muscle fibres.""SUBINVOLUTION PERITONITIS."(?) DR.DOUGLAS A. MITCHELL (Bath) writes: The histrionic genius of the vermiform sppendix is so generally recognized nowadays that it is apt to be blamed for the large majority of lower abdo- minal infections where no other gross lesion is demonstrable.in recent years I bave seen several cases of acute abdominal crises in women necessitating operation, in which the greatest
Monoclonal Antibodies for the Diagnosis and Treatment of Transplant Rejection
Authors: P. Russell
Journal: Annual Review of Medicine (1984)

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the cause of coronavirus disease 2019 (COVID-19), emerged in China in December 2019 and quickly spread around the globe, killing more than 4 million people and causing a severe economic crisis. ...Read More
Subcutaneous Splenosis
Authors: JOHN F. HIBBELN, ANDREW C. WILBUR, VIRGINIA C. SCHREINER, DONALD W. TREPASHKO
Journal: Clinical Nuclear Medicine (1995)

Splenosis is the ectopic implantation of splenic tissue, usually as the result of trauma. Intraperitoneal, Intrathoracic, and retroperitoneal sites of implantation have been reported. The authors report a case of subcutaneous splenosis Involving the abdominal wall that was imaged with CT and scintigraphy.
Phase III Randomized Study of Two Fluorouracil Combinations With Either Interferon Alfa-2a or Leucovorin for Advanced Colorectal Cancer
Journal: Journal of Clinical Oncology (1996)

The name of a Corfu-A Study Group member listed in the Appendix of the report entitled, "Phase III Randomized Study of Two Fluorouracil Combinations With Either Interferon Alfa-2a or Leucovorin for Advanced Colorectal Cancer" by the Corfu-A Study Group (J Clin Oncol 13:921–928, 1995) appeared incorrectly. The third name listed should have appeared as "R. Bell."
A System of Genito-Urinary Diseases, Syphilology and Dermatology,
Journal: JAMA (1894)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
1153 THE EFFECT OF HEPATIC IMPAIRMENT ON THE SAFETY, PHARMACOKINETICS AND ANTIVIRAL ACTIVITY OF PSI-938 IN HEPATITIS C INFECTED SUBJECTS TREATED FOR SEVEN DAYS
Authors: M. Rodriguez-Torres, E. Lawitz, M.T. Cornpropst, J.M. Denning, D. Clemons, L. McNair, L. Fang, M.M. Berrey, W.T. Symonds
Journal: Journal of Hepatology (2012)
Statement on Heart Transplantation
Journal: JAMA (1969)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Multiple Risk Factor Intervention Trial. Risk factor changes and mortality results. Multiple Risk Factor Intervention Trial Research Group. 1982
Journal: JAMA (1997)

The Multiple Risk Factor Intervention Trial was a randomized primary prevention trial to test the effect of a multifactor intervention program on mortality from coronary heart disease (CHD) in 12,866 high-risk men aged 35 to 57 years. Men were randomly assigned either to a special intervention (SI) program consisting of stepped-care treatment for hypertension, counseling for cigarette smoking, and dietary advice for lowering blood cholesterol levels, or to their usual sources of health care in the community (UC). Over an average follow-up period of seven years, risk factor levels declined in both groups, but to a greater degree for the SI men. Mortality from CHD was 17.9 deaths per 1,000 in the SI group and 19.3 per 1,000 in the UC group, a statistically nonsignificant difference of 7.1% (90% confidence interval, -15% to 25). Total mortality rates were 41.2 per 1,000 (SI) and 40.4 per 1,000 (UC). Three possible explanations for these findings are considered: (1) the overall intervention program, under these circumstances, does not affect CHD mortality; (2) the intervention used does affect CHD mortality, but the benefit was not observed in this trial of seven years' average duration, with lower-than-expected mortality and with considerable risk factor change in the UC group; and (3) measures to reduce cigarette smoking and to lower blood cholesterol levels may have reduced CHD mortality within subgroups of the SI cohort, with a possibly unfavorable response to antihypertensive drug therapy in certain but not all hypertensive subjects. This last possibility was considered most likely, needs further investigation, and lends support to some preventive measures while requiring reassessment of others.
Intravenous drug use and HIV: evidence for action now
Authors: None The Lancet
Journal: The Lancet (2006)

For many of those lucky enough to have access to effective treatment, HIV/AIDS is increasingly becoming a manageable chronic condition, instead of a death sentence. And the numbers of new infections are declining in some countries, largely because of education, behavioural changes, and the implementation of proven prevention strategies. But for at least one group, intravenous drug users, rates of HIV infection are rocketing.
Abstract 1143: The circulating tumor cell (CTC) microenvironment visualized by color coded imaging
Authors: Atsushi Suetsugu, Tomoyuki Satake, Miki Nakamura, Masahito Shimizu, Shigetoyo Saji, Hisataka Moriwaki, Robert M. Hoffman
Journal: Cancer Research (2019)

Abstract Background/Aim: An important question is whether cancer cells circulate with stromal cells. A color-coded mouse model of metastatic lymphoma was utilized to investigate the microenvironment of CTC clusters using fluorescent-protein imaging. Materials and Methods: EL-4 mouse lymphoma cells expressing red fluorescent protein (RFP) were injected into the spleen of transgenic C57BL6-green fluorescent protein (GFP) mice. The cellular composition of CTC clusters both in heart blood and portal blood was imaged with confocal microscopy. Results: CTC clusters comprised 8.8% of CTCs determined by color-coded imaging. Heterotypic CTC clusters containing other types of cells were distinguishable from homotypic CTCs. Heterotypic CTC clusters comprising cancer cells and fibroblasts were more rare than homotypic ones. Heterotypic CTC clusters with fibroblasts were observed only in portal blood, not in heart blood. Conclusion: CTCs can form clusters, which may contain fibroblast or other stromal cells that may play a role in promoting CTC metastasis. Citation Format: Atsushi Suetsugu, Tomoyuki Satake, Miki Nakamura, Masahito Shimizu, Shigetoyo Saji, Hisataka Moriwaki, Robert M. Hoffman. The circulating tumor cell (CTC) microenvironment visualized by color coded imaging [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2019; 2019 Mar 29-Apr 3; Atlanta, GA. Philadelphia (PA): AACR; Cancer Res 2019;79(13 Suppl):Abstract nr 1143.
Diagnostic Cholangiopancreatography
Authors: R Schöfl, M Haefner
Journal: Endoscopy (2003)

As in recent years, the articles on diagnostic endoscopic retrograde cholangiopancreatography (ERCP) published between July 2001 and June 2002 again reflect a defensive attitude and are mainly concerned with magnetic resonance cholangiopancreatography (MRCP) and the complications associated with the new imaging method. Diagnostic ERCP is declining in importance and has held its position mainly due to new advances in tissue sampling, pressure measurement, and the use of echo probes and miniature endoscopes. Problems of training in ERCP have still not yet been resolved, due to the contradictions inherent in low case loads, the desire to offer a wide spectrum of training, and issues of quality assurance.
Corrections
Authors: Gae ¨lle Leroux, Nathalie Costedoat-Chalumeau, Zahir Amoura, Jean- Charles Piette, Jean-Se ´bastien Hulot, Guy Aymard, Philippe Lechat
Journal: Annals of the Rheumatic Diseases (2007)

correlation was found between the number of cigarettes and the blood hydroxychloroquine concentrations (R 2 = 0.09).Finally, no more differences were observed between smokers and nonsmokers when the analyses were restricted to SLE patients.Our results regarding blood hydroxychloroquine and desethylchloroquine concentrations in 223 treated patients did not show any significant relationship between cigarette smoking and hydroxychloroquine or desethylchloroquine concentrations.This is a strong argument against a direct effect of smoking on hydroxychloroquine metabolism.Another mechanism of interaction (as a modification of the lysosomal accumulation of antimalarial agents) or a direct deleterious effect of smoking on cutaneous lesions seems more likely.
Ependymomas
Authors: Kanwal P. S. Raghav, Mark R. Gilbert
Journal: Neuro-Oncology (2012)

Ependymal tumors are glial neoplasms believed to arise from ependymal cells that line the ventricular system. Ependymomas may occur anywhere along the neuroaxis and Grade 1 tumors (myxopapillary ependymomas and subependymomas) are biologically distinct from Grade 2 (low grade) and Grade 3 (anaplastic) ependymomas. The molecular pathology of ependymomas is poorly understood. Although a consensus regarding management of ependymomas is lacking, a basic tenet of treatment, for both pediatric and adult tumors, is the need for a gross total resection, if feasible. The role of radiation therapy is not as clear, but most would recommend focal radiation therapy for patients with subtotally resected tumors, for anaplastic tumors, and possibly for those with totally resected (especially posterior fossa) tumors. The benefit of chemotherapy, as regards long-term tumor control, is unclear.
Received
Journal: JAMA (1997)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Time
Authors: Edward J. Volpintesta
Journal: Annals of Internal Medicine (1998)

Letters15 April 1998TimeEdward J. Volpintesta, MDEdward J. Volpintesta, MDBethel Medical Group; Bethel, CT 06801Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-128-8-199804150-00032 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail TO THE EDITOR:I write regarding Dr. Davidoff's comments [1] about the diminishing amount of time we have to spend with patients. There are understandable reasons why we have sped up the doctor visit. For most physicians, particularly under managed care, the only way to keep up with overhead and make a decent living is to see more patients per hour.In addition, patients expect us to be perfect because of our technology. So, it is easy to tell ourselves that spending time with them isn't as important as preserving our aura of being “perfect.” And sadly, the specter of ...References1. Davidoff F. Time [Editorial]. Ann Intern Med. 1997; 127:483-5. Google Scholar Author, Article, and Disclosure InformationAffiliations: Bethel Medical Group; Bethel, CT 06801 PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics 15 April 1998Volume 128, Issue 8Page: 698KeywordsEpilepsyPatients Issue Published: 15 April 1998 CopyrightCopyright © 1998 by American College of Physicians. All Rights Reserved.PDF DownloadLoading ...
Dissection of experimental asthma with DNA microarray analysis identifies arginase in asthma pathogenesis
Authors: N. Zimmermann
Journal: Journal of Clinical Investigation (2003)

Asthma is on the rise despite intense, ongoing research underscoring the need for new scientific inquiry. In an effort to provide unbiased insight into disease pathogenesis, we took an approach involving expression profiling of lung tissue from mice with experimental asthma. Employing asthma models induced by different allergens and protocols, we identified 6.5% of the tested genome whose expression was altered in an asthmatic lung. Notably, two phenotypically similar models of experimental asthma were shown to have distinct transcript profiles. Genes related to metabolism of basic amino acids, specifically the cationic amino acid transporter 2, arginase I, and arginase II, were particularly prominent among the asthma signature genes. In situ hybridization demonstrated marked staining of arginase I, predominantly in submucosal inflammatory lesions. Arginase activity was increased in allergen-challenged lungs, as demonstrated by increased enzyme activity, and increased levels of putrescine, a downstream product. Lung arginase activity and mRNA expression were strongly induced by IL-4 and IL-13, and were differentially dependent on signal transducer and activator of transcription 6. Analysis of patients with asthma supported the importance of this pathway in human disease. Based on the ability of arginase to regulate generation of NO, polyamines, and collagen, these results provide a basis for pharmacologically targeting arginine metabolism in allergic disorders.
Methyprylone
Authors: M. M. Glatt
Journal: BMJ (1957)

A combinatorial method is described for grouping cases with multiple malformations for the purpose of identifying previously undescribed syndromes. This method includes ways of carrying out 9tight9 or 9loose9 grouping, of allowing for variability of reporting of physical features by different observers, and of minimising the number of 9spurious9 groups. Evaluation using a test data set of known dysmorphic syndromes showed that the method provides a feasible and useful means of grouping undiagnosed cases.
The Physiological Effects of Radiant Energy.
Journal: JAMA (1933)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Fighting Foes Too Small to See.
Journal: JAMA (1924)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Poster Discussions
Authors: M. Grotz, A. Hohensee, G. Regel, D. Remmers, H. Tscherne, Kazuhiro Kasai, Yoshihiko Suzuki, Keiitchi Ikegami, Tetsuo Yukioka, Hiroharu Matsuda, Shuji Shimazaki, D. Müller, A. Dávid, J. Richter, G. Muhr
Journal: Intensive Care Medicine (1996)
Silicone Breast Implants and Sclerodermalike Esophageal Disease in Breast-fed Infants
Authors: Wendy Anne Epstein
Journal: JAMA (1996)

<h3>To the Editor.</h3> —The 1994 article by Drs Levine and Ilowite<sup>1</sup>concluded, "A relationship appears to exist between breast-feeding by mothers with silicone [breast] implants and abnormal esophageal motility," a feature of systemic sclerosis. Letters in response<sup>2</sup>detailed deficiencies in the science and reporting of the study. It is known that the children of mothers with connective tissue diseases are at greater risk of contracting these diseases. The term<i>familial scleroderma</i>refers to the increased incidence of systemic sclerosis among first-degree relatives of patients with scleroderma. The human lymphocyte antigen haplotypes, autoantibodies, and clinical features associated with systemic sclerosis are more prevalent among first-degree relatives of patients with systemic sclerosis.<sup>3</sup>Maternal autoantibodies can transfer to the child via cord blood and breast milk.<sup>4</sup>The phenomenon of "neonatal scleroderma" has been described.<sup>5</sup> Therefore, it was correct that Drs Levine and Ilowite excluded mothers with scleroderma from